Journal of Commercial Biotechnology — March 2008

The March 2008 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract of each article:

Volume 14, Issue 2
Editorial
Yali Friedman

A new approach to improve technology commercialisation in university medical schools
Courtney Price, Richard Huston and Arlen D Meyers

Export compliance for life sciences
John Avellanet

Biotechnology business models work: Evidence from the pharmaceutical marketplace
J Leslie Glick

Valuing biotechnology companies: Does classification by technology type help?
Jacqueline Loh and Robert Brooks

Risk management for the biotechnology industry: A Canadian perspective
Sandra Vanderbyl and Sherry Kobelak

Singapore’s biomedical sciences landscape
Keat-Chuan Yeoh

Social responsibility for the use of genes, genomes and biotechnology in biotechnology companies: A commentary from the bioethical viewpoint
Yoshihiro Okada and Kazuo N Watanabe

Legal & Regulatory Update
Bird & Bird and Reed Smith

Maryland and Virginia unite at 2007 Mid-Atlantic Bio Conference
Harley King

Book Review — Stem Cell Wars: Inside Stories from the Frontlines
Grant H Skrepnek

The Journal of Commercial Biotechnology is online at http://www.palgrave-journals.com/jcb. If purchasing a subscription, please use subscriber code NH0707G01.

Share this page

Tagged as: Journal of Commercial Biotechnology